BioCentury
ARTICLE | Politics, Policy & Law

Trump’s divide and conquer Part B plan

Trump using a divide and conquer approach to Part B drug plan

October 27, 2018 3:23 AM UTC

While its rollout was timed to provide Republicans with ammunition in the last-minute run to the mid-term elections, the Trump administration’s proposal to revamp Part B drug payments won’t go into effect until 2020, at the earliest.

The biopharma industry, which loathes both the specifics of the plan and the precedents it would set, has about a year to derail the White House effort or water it down. Most galling to the industry is the plan to create an international reference pricing scheme...